If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.685    0.065 (1.41%)
Bid:
4.70
Ask:
4.725
Spread: 0.025 (0.532%)
Market Cap: £224.86m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

COVID-19 Update

17 Mar 2020 07:00

RNS Number : 4178G
Seeing Machines Limited
17 March 2020
 

 

Seeing Machines Limited

 

17 March 2020

 

COVID-19 UPDATE

 

Seeing Machines Limited (AIM: SEE, "Seeing Machines" or the "Company"), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, provides an update as global markets react to the rapidly evolving circumstances around the spread of COVID-19.

 

There is an underlying and unstoppable movement for improved safety across all industry verticals and transport sectors, globally. Seeing Machines' driver monitoring system technology benefits significantly from this and expects to continue to do so in the medium and long term.

 

The immediate global impact from COVID-19 is unprecedented and, as governments across the world make a number of significant decisions on a day-to-day basis and implement a range of precautionary measures, many of which impinge on the movement of people and goods, this presents an obvious challenge to the transport sectors which Seeing Machines' technology and products serve.

 

Accordingly, despite the otherwise positive momentum across all transport sectors and significant confirmed order books for both the Fleet and Automotive divisions, the short to medium-term outlook is uncertain and it is possible that the Company will be impacted by these conditions.

 

Specifically, the Company's current view on those potential impacts is as follows:

 

Automotive

 

· Given the relatively early stage of existing Automotive programs and the timing of projected revenue from those programs, we are of the view that there is likely to be no material impact to this business segment as a result of COVID-19.

· Accordingly, at this stage there is no indication that there will be any impact to the current projected Automotive order book of A$200m, the bulk of which is expected to be recognised between 2021 and 2024.

 

Fleet

 

· At this point in time, and as previously announced, the Company's Guardian product supply chain is minimally affected by COVID-19 and the Company holds sufficient stock in various locations to allow it to achieve the previously-stated minimum connections target for FY20.

· However, anticipated business interruption for Fleet customers, resulting indecision on capital expenditure, as well as potential increased supply chain pressure which will reduce availability of vehicles for new installations, will likely have a significant impact on Guardian installation rates and future sales over the coming months.

· Seeing Machines' contract manufacturer in China has indicated that production of Guardian has recommenced and the Company expects to have access to some additional stock, as manufacturing resumes to full capacity, however the quantity of stock available for FY21 installations is yet to be confirmed.

· The timing of future stock deliveries is currently unconfirmed and further information will be provided as it comes to hand.

· While the Company still expects the Fleet business to achieve significant growth year-on-year, it is unable to accurately forecast the impact or the potential duration of these issues to future Guardian sales at this point in time.

 

Aviation

 

· There has been a very significant impact from COVID-19 on airline operators around the world; however, as the Aviation business represents only a small proportion of the Company's revenue forecast for FY20, the ongoing situation is not expected to have any material impact on that business segment in the near term.

 

As a consequence of the various factors outlined above, the Company believes it prudent to withdraw current guidance in respect of sales revenue, annualised recurring revenue and the number of connected Guardian units by 30 June 2020.

 

In response, the Company is implementing contingency plans and cost containment initiatives which, together with the previously-announced A$47.3m of net cash at 31 December 2019, are designed to maximise the Company's cash runway.

 

These measures leave Seeing Machines in a strong position and aim to ensure its ability to finance ongoing operations.

 

Enquiries:

 

Seeing Machines Limited

+61 2 6103 4700

Paul McGlone - CEO

Sophie Nicoll - Corporate Communications

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Neil McDonald

Pete Lynch

+44 131 220 6939

 

 

Stifel Nicolaus Europe Limited (Joint Broker)

+44 20 7710 7600

Alex Price

Nick Adams

 

 

 

Antenna Group for Seeing Machines (Media Enquiries)

 

seeingmachines@antennagroup.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

The person responsible for arranging the release of this announcement on behalf of Seeing Machines is Sophie Nicoll, SVP, Corporate Communications.

 

About Seeing Machines (LSE: SEE), a global company founded in 2000 and headquartered in Australia, is an industry leader in vision-based monitoring technology that enable machines to see, understand and assist people. Seeing Machines' technology portfolio of AI algorithms, embedded processing and optics, power products that need to deliver reliable real-time understanding of vehicle operators. The technology spans the critical measurement of where a driver is looking, through to classification of their cognitive state as it applies to accident risk. Reliable "driver state" measurement is the end-goal of Driver Monitoring Systems (DMS) technology. Seeing Machines develops DMS technology to drive safety for Automotive, Commercial Fleet, Off-road and Aviation. The company has offices in Australia, USA, Europe and Asia, and supplies technology solutions and services to industry leaders in each market vertical.

 

www.seeingmachines.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDQDLBFBXLBBBV
Date   Source Headline
7th Aug 20097:00 amRNSAppointment of broker
11th Jun 20099:12 amRNSDirector/PDMR Shareholding
21st May 20097:58 amRNSDirector Shareholding
11th Mar 20097:00 amRNSReviewed Interim Results
18th Feb 20097:00 amRNSRestructuring of the business
28th Jan 20099:41 amRNSTrading update and notice of results
1st Dec 20088:14 amRNSChange of Registered Office
27th Nov 20088:08 amRNSResult of AGM
29th Oct 200810:52 amRNSNotice of AGM
23rd Sep 20087:00 amRNSFinal Results
17th Sep 20088:37 amRNSNotice of Final Results
26th Aug 20088:33 amRNSNEW FACEAPI PRODUCT RELEASE
23rd Jul 20087:37 amRNSFirst Expected Profit Report
7th May 20088:08 amRNSNORTH AMERICAN OPERATION
7th Apr 200812:00 pmRNSChange of Broker
4th Mar 20087:59 amRNSInterim Results
4th Mar 20087:51 amRNSMajor contract gain
13th Feb 20088:27 amRNSHolding in Company
28th Dec 20079:11 amRNSAnnual Report
11th Dec 200710:54 amRNSChange of Adviser
29th Nov 200710:03 amRNSAGM Results
8th Nov 200712:38 pmRNSDirector/PDMR Shareholding
8th Nov 200712:34 pmRNSGlaucoma Device at AAO
31st Oct 20079:26 amRNSCompletion of Placing-Replace
31st Oct 20077:01 amRNSCompletion of Placing
26th Oct 20079:35 amRNSShareholder Approval
17th Oct 20072:21 pmRNSDirector/PDMR Shareholding
15th Oct 20079:23 amRNSCFO Appointment
25th Sep 200710:23 amRNSFurther Placing
24th Sep 20071:12 pmRNSFinal Results
24th Sep 20071:00 pmRNSFundraising
15th Aug 200712:43 pmRNSAIM Rule 26 Compliance
15th Aug 20079:27 amRNSFDA Approval for Truefield
2nd Jul 20077:01 amRNSNew Product Releases
29th Jun 200710:11 amRNSMaster License Agreement
22nd May 200711:15 amRNSLicensing agreement signed
8th May 20077:02 amRNSGlaucoma Device Demonstrated
28th Mar 20072:40 pmRNSInterim Results
14th Mar 200710:45 amRNSAward win for glaucoma device
12th Mar 20077:02 amRNSAddition to product released
19th Dec 200610:06 amRNSTotal Voting Rights
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.